These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Endocrine complications in transfusion dependent thalassaemia in Penang Hospital. Ong CK; Lim SL; Tan WC; Ong EE; Goh AS Med J Malaysia; 2008 Jun; 63(2):109-12. PubMed ID: 18942294 [TBL] [Abstract][Full Text] [Related]
8. Management of thalassemia in Los Angeles. Hyman CB; Ortega JA; Costin G; Landing B; Lazerson J; Leimbrock S; Lurie P Birth Defects Orig Artic Ser; 1976; 12(8):43-52. PubMed ID: 1009234 [No Abstract] [Full Text] [Related]
9. Management of thalassemias: growth and development, hormone substitution, vitamin supplementation, and vaccination. Kattamis CA; Kattamis AC Semin Hematol; 1995 Oct; 32(4):269-79. PubMed ID: 8560284 [No Abstract] [Full Text] [Related]
10. The Thalassemia center of Antalya State Hospital: 15 years of experience (1994 to 2008). Canatan D J Pediatr Hematol Oncol; 2013 Jan; 35(1):24-7. PubMed ID: 23128337 [TBL] [Abstract][Full Text] [Related]
11. [Future perspectives in the treatment of thalassemia major]. Girot R Ann Pediatr (Paris); 1985 Nov; 32(9):801-7. PubMed ID: 3911858 [No Abstract] [Full Text] [Related]
12. Critical appraisal of growth retardation and pubertal disturbances in thalassemia. Chatterjee R; Bajoria R Ann N Y Acad Sci; 2010 Aug; 1202():100-14. PubMed ID: 20712780 [TBL] [Abstract][Full Text] [Related]
13. Current concepts in the overall management of thalassemia. Propper RD Ann N Y Acad Sci; 1980; 344():375-83. PubMed ID: 6930877 [No Abstract] [Full Text] [Related]
14. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine. Giardina PJ; Grady RW Semin Hematol; 1995 Oct; 32(4):304-12. PubMed ID: 8560288 [TBL] [Abstract][Full Text] [Related]